[Clinical research: who owns the data?]

Area of Science:

• Medical research ethics
• Intellectual property in science
• Clinical trial data management

Context:

• Clinical trials involving medicines and devices often involve collaborations between academic researchers and commercial entities.
• This collaboration can create a conflict between the company's desire to protect proprietary knowledge (e.g., for patents) and the scientist's need for timely publication.

Purpose:

• To explore the inherent tension between commercial interests and scientific dissemination in collaborative clinical research.
• To examine how contractual agreements in the Netherlands attempt to resolve these conflicts.
• To identify and discuss practical loopholes in these agreements.

Summary:

• Clinical trial data itself is factual and unownable, but the derived knowledge holds commercial value and can be proprietary.
• Dutch law utilizes contractual agreements to define the relationship between commercial companies and medical centers in research.
• Despite theoretical frameworks, practical challenges and loopholes persist in managing intellectual property and publication rights.

Impact:

• Highlights the complexities of intellectual property and knowledge sharing in pharmaceutical and medical device research.
• Informs the development of more robust contractual frameworks for industry-sponsored clinical trials.
• Underscores the importance of addressing practical discrepancies between legal agreements and research realities.